Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Maqui Berry Standardized Extract
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : University of Memphis
Deal Size : Inapplicable
Deal Type : Inapplicable
Assessment of Delphinol® Dose on Vascular Function
Details : Delphinol (Maqui Berry Standardized Extract) is a Plant Extract/Herbal drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of undefined medical condition.
Product Name : Delphinol
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 29, 2025
Lead Product(s) : Maqui Berry Standardized Extract
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : University of Memphis
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Avena Sativa
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
Acute and Chronic Effects of Avena Sativa on Cognition and Stress
Details : Avena Sativa is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition Disorders.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 28, 2018
Lead Product(s) : Avena Sativa
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
